ISRCTN16114765
Active, not recruiting
未知
A prospective feasibility study to assess ex vivo real-time analysis of detrusor muscle status at time of primary transurethral resection of bladder tumour (TURBT) using fluorescence confocal microscopy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Bladder cancer
- Sponsor
- Imperial College Healthcare NHS Trust
- Enrollment
- 35
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients undergoing initial or first transurethral resection of bladder tumour (TURBT) for suspected bladder cancer.
Exclusion Criteria
- •1\. Radiological or clinical suspicion of muscle\-invasive bladder cancer (cT2\-T4\)
- •2\. Prior diagnosis of NMIBC or MIBC on prior resection
- •3\. Patients who do not consent for ex vivo tissue research through Imperial College Healthcare Tissue Bank (ICHTB)
- •4\. Patients enrolled in concurrent clinical trials requiring ex vivo tissue for research
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Prospective study for evaluating feasibily and utility of comprehensive genomic profiling test before initial systemic treatment in advanced malignant solid tumor patientsAdvanced or recurrent solid cancer (non-small cell lung cancer, breast cancer, gastric cancer, colorectal cancer, pancreatic cancer, or biliary tract cancer)JPRN-UMIN000040743ational Cancer Center200
Completed
Not Applicable
A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancerJPRN-UMIN000008574Anaplastic Thyroid Carcinoma Consortium Japan50
Completed
Not Applicable
A clinical feasibility study to evaluate the effectiveness and safety of VivescOs™ as bone graft for reconstruction of intra-oral osseous defectsISRCTN92152389IsoTis NV (The Netherlands)10
Not yet recruiting
Phase 2
A Study Where twice weekly radiotherapy will be given internally during external beam radiotherapy treatment to see the feasibility toxicity and efficacy in locally advanced cervical cancerHealth Condition 1: - Health Condition 2: C538- Malignant neoplasm of overlappingsites of cervix uteriCTRI/2019/10/021486RADIOTHERAPY DEPARTMENT SSKM HOSPITA
Not yet recruiting
Not Applicable
An exploratory study to evaluate in vivo, ex vivo and clinical hypersensitivity reactions after first-time treatment with complement-reactogenic infusionsNL-OMON56981Centre for Human Drug Research60